Novartis Digital Health Venture Capital
Founded in 2015, dRx Capital is Novartis' Digital Health Venture Fund investing in entrepreneurs transforming healthcare through data and digital technology. The fund invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
Jul 24, 2019
Freenome
|
Series B | $160M | Biotechnology | — |
Jan 3, 2019
Science 37
|
Series D | $35M | Biotechnology | — |
Apr 25, 2017
Science 37
|
Series C | $35M | Biotechnology | — |
Oct 18, 2016
Science 37
|
Series B | $31M | Biotechnology | — |